Publications scientifiques Bordet

A preoperative window-of-opportunity study of oral SERD, imlunestrant, in newly diagnosed ER-positive, HER2-negative early breast cancer: Results from EMBER-2 Study.
Auteurs Neven P, Stahl N, Vidal M, Martín M, Kaufman PA, Harbeck N, Hunt KK, Carter S, Bidard FC, Fasching PA, Aftimos P, Wheatley D, Hamilton E, Aft R, Kulkarni S, Schmid P, Bhave M, Ismail-Khan R, Karacsonyi C, Estrem ST, Nguyen B, Ozbek U, Yuen E, Rodrik-Outmezguine V, Ciruelos E
Auteurs (entité) AFTIMOS PHILIPPE
Revue Clin Cancer Res
Date de publication 2024-10

Measurable residual disease assessment prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndromes: a 20-year monocentric study.
Auteurs Wery AR, Salaroli A, Andreozzi F, Paesmans M, Dewispelaere L, Heimann P, Wittnebel S, Lewalle P
Auteurs (entité) WITTNEBEL SEBASTIAN
Revue Ann Hematol
Date de publication 2024-10

Measurable residual disease assessment prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndromes: a 20-year monocentric study.
Auteurs Wery AR, Salaroli A, Andreozzi F, Paesmans M, Dewispelaere L, Heimann P, Wittnebel S, Lewalle P
Auteurs (entité) ANDREOZZI FABIO
Revue Ann Hematol
Date de publication 2024-10

Measurable residual disease assessment prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndromes: a 20-year monocentric study.
Auteurs Wery AR, Salaroli A, Andreozzi F, Paesmans M, Dewispelaere L, Heimann P, Wittnebel S, Lewalle P
Auteurs (entité) LEWALLE PHILIPPE
Revue Ann Hematol
Date de publication 2024-10

Measurable residual disease assessment prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndromes: a 20-year monocentric study.
Auteurs Wery AR, Salaroli A, Andreozzi F, Paesmans M, Dewispelaere L, Heimann P, Wittnebel S, Lewalle P
Auteurs (entité) SALAROLI ADRIANO
Revue Ann Hematol
Date de publication 2024-10

Evaluation of ChatGPT-4's Performance in Therapeutic Decision-Making During Multidisciplinary Oncology Meetings for Head and Neck Squamous Cell Carcinoma.
Auteurs Alami K, Willemse E, Quiriny M, Lipski S, Laurent C, Donquier V, Digonnet A
Auteurs (entité) WILLEMSE ESTHER
Revue Cureus
Date de publication 2024-09

Evaluation of ChatGPT-4's Performance in Therapeutic Decision-Making During Multidisciplinary Oncology Meetings for Head and Neck Squamous Cell Carcinoma.
Auteurs Alami K, Willemse E, Quiriny M, Lipski S, Laurent C, Donquier V, Digonnet A
Auteurs (entité) LIPSKI SAMUEL MICHAEL
Revue Cureus
Date de publication 2024-09

Evaluation of ChatGPT-4's Performance in Therapeutic Decision-Making During Multidisciplinary Oncology Meetings for Head and Neck Squamous Cell Carcinoma.
Auteurs Alami K, Willemse E, Quiriny M, Lipski S, Laurent C, Donquier V, Digonnet A
Auteurs (entité) QUIRINY MARIE
Revue Cureus
Date de publication 2024-09

Evaluation of ChatGPT-4's Performance in Therapeutic Decision-Making During Multidisciplinary Oncology Meetings for Head and Neck Squamous Cell Carcinoma.
Auteurs Alami K, Willemse E, Quiriny M, Lipski S, Laurent C, Donquier V, Digonnet A
Auteurs (entité) DIGONNET ANTOINE
Revue Cureus
Date de publication 2024-09

Hôpital Erasme

Consultez toutes les publications scientifiques d'Erasmus

Publications scientifiques d'Erasmus

Consultez toutes les publications scientifiques de l'Hôpital pédiatrique Reine Fabiola

Publications scientifiques de l'Hôpital pour enfants Reine Fabiola

Consultez toutes les publications scientifiques de Jules Bordet

Publications scientifiques de Jules Bordet